Your browser doesn't support javascript.
loading
Validation of the Guy's Neurological Disability Scale as a screening tool for cognitive impairment in multiple sclerosis.
Akatani, Ritsu; Chihara, Norio; Tachibana, Hisatsugu; Koto, Shusuke; Kowa, Hisatomo; Kanda, Fumio; Matsumoto, Riki; Toda, Tatsushi.
Afiliação
  • Akatani R; Division of Neurology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
  • Chihara N; Division of Neurology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan. Electronic address: chiharan@med.kobe-u.ac.jp.
  • Tachibana H; Division of Neurology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
  • Koto S; Division of Neurology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
  • Kowa H; Department of Rehabilitation, Kobe University Graduate School of Health Sciences, Kobe 654-0142, Japan.
  • Kanda F; Division of Neurology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
  • Matsumoto R; Division of Neurology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
  • Toda T; Department of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Mult Scler Relat Disord ; 35: 272-275, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31442905
ABSTRACT

OBJECTIVES:

Cognitive impairment is a common symptom affecting daily activities of the patients with multiple sclerosis (MS). Various cognitive evaluation tests are available, yet most of them are complex and time-consuming to perform in outpatient clinics. In this study, we aimed to validate a Japanese version of the Guy's Neurological Disability Scale (GNDS) as a user-friendly tool to evaluate comprehensive disabilities in MS including cognitive function.

METHODS:

Questions of the GNDS were translated into Japanese and named GNDS-J. Forty-four patients were examined by the Expanded Disability Status Scale (EDSS), the Paced Auditory Serial Addition Test (PASAT), the Symbol Digit Modalities Test (SDMT), the vitality scale, and the GNDS-J in the same time at remission state.

RESULTS:

The GNDS-J scores correlated with the EDSS scores(r = 0.61), and inversely correlated with the PASAT2/1(r=-0.56/-0.49) scores and the SDMT scores (r=-0.68), whereas the GNDS-J did not show any correlation with the vitality scale. Furthermore, eleven patients were evaluated over 5 years for changes in these scores. Eight out of 11 patients had exacerbated GNDS, and all of these patients experienced clinical relapse during this period.

CONCLUSION:

The GNDS-J is a valid tool to perform in outpatient clinics, which could provide a comprehensive scale for evaluating symptoms of MS, thus the disease activity by repeated measure.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cognição / Disfunção Cognitiva / Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cognição / Disfunção Cognitiva / Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article